Category: CLE, Bankruptcy and Debtor-Creditor (CLE), Business & Corporations (CLE), Commercial & Consumer Law (CLE), Constitutional Law (CLE), Criminal Law (CLE), Education Law (CLE), Elder Law (CLE), Employment and Labor Law (CLE), Environmental Law (CLE), Family Law (CLE), Government Law (CLE), Health Law (CLE), Intellectual Property Law (CLE), International Law (CLE), Litigation (CLE), Real Property Law (CLE), Taxation (CLE), Tort Law (CLE), Trusts, Wills & Estates (CLE) (show less)
|
Credits: 3.0 general credit hours
Description: This popular annual class features a lively panel discussion of the issues and cases that will be before the Supreme Court in the next term (OT24). Our moderator will interview our expert panelists to bring out unique insights and engage them in a point/counterpoint discussion for some of the most interesting cases and issues. Those who attend will also receive insights into the 2023 – 2024 Supreme Court term’s highlights. Our distinguished panel includes experienced Supreme Court practitioners who are uniquely qualified to look at the Court’s trends and statistics as well as to provide insight into its decisions.
Faculty: John P. Elwood, Arnold & Porter Kaye Scholer LLP; Elaine J. Goldenberg, Munger, Tolles & Olson LLP; William M. Jay, Goodwin Procter LLP; Jaime A. Santos, Goodwin Procter LLP; and Daniel Woofter, Goldstein, Russell & Woofter LLC (Moderator)
Fees: $89 D.C. Bar Communities Members, $99 D.C. Bar Members, $109 Government and Nonprofit Attorneys, and $129 Others
The D.C. Bar CLE Program now offers discounted group registration rates! For more information, contact the CLE Office at CLE@dcbar.org or 202-626-3488.
Special Notice (In-Person Attendees Only)
If you are planning to attend this event in person at the D.C. Bar, please click here for more information concerning the Bar’s COVID guidelines and visitor policy. Also, if you are attending a class in person, we encourage you to bring a device or to download the materials prior to class as we will not be providing hard copies.